drugset / Trial / NCT00670202
Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
Phase 2
Terminated
2 enrolled
Brigham and Women's Hospital
Doris Duke Charitable Foundation · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
To evaluate the causal relationship between Rho/Rho kinase overactivity and mechanisms of vascular dysfunction in patients with atherosclerosis.
Timeline
- Start
- 2008-03-13
- Primary completion
- 2011-01-20
- Completion
- 2011-01-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fasudil | Small molecule | 40 mg | — |